[Treatment of Raynaud's phenomenon with alpha-lytic agents].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D011928:Raynaud Disease / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists
Traitement du phénomène de Raynaud par les alpha-lytiques.